The PE Ratio as of December 2025 (TTM) for Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) is -48.50

According to Chongqing Lummy Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -48.50. This represents a change of -10.12% compared to the average of -53.96 of the last 4 quarters.

Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) Historical PE Ratio (quarterly & annually)

How has 300006.SZ PE Ratio performed in the past?

The mean historical PE Ratio of Chongqing Lummy Pharmaceutical Co., Ltd. over the last ten years is 77.66. The current -48.50 PE Ratio has changed -6345.52% with respect to the historical average. Over the past ten years (40 quarters), 300006.SZ's PE Ratio was at its highest in in the June 2020 quarter at 65.38K. The PE Ratio was at its lowest in in the September 2023 quarter at -2282.00.

Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Chongqing Lummy Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) Average PE Ratio

How has 300006.SZ PE Ratio performed in the past?

The current PE Ratio of Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) PE Ratio vs. Peers

How is 300006.SZ’s PE Ratio compared to its peers?

Chongqing Lummy Pharmaceutical Co., Ltd.’s PE Ratio is less than Harbin Medisan Pharmaceutical Co., Ltd. (-21.86), less than Tibet Weixinkang Medicine Co., Ltd. (20.97), less than Wuhan Hiteck Biological Pharma Co.,Ltd (-19.89), greater than Suzhou MedicalSystem Technology Co., Ltd. (-59.17), less than Beijing Beilu Pharmaceutical Co., Ltd (127.57), less than Zhejiang Int'l Group Co.,Ltd. (12.11), greater than Zhejiang Starry Pharmaceutical Co.,Ltd. (-142.84), less than Berry Genomics Co.,Ltd (-15.48), less than Yabao Pharmaceutical Group Co., Ltd (20.74), less than Ningbo Menovo Pharmaceutical Co., Ltd. (42.59),

Build a custom stock screener for Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chongqing Lummy Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chongqing Lummy Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.